
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-03-18 | Sheri Biggs(R-SC03) | house | Sale | $1,001 - $15,000 |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net revenues | $23.28B-3.1% | $24.02B-1.9% | $24.48B-2.4% | $25.10B-3.5% | $26.01B |
| Cost of sales | $5.60B-7.9% | $6.08B-2.3% | $6.22B-3.5% | $6.44B-9.5% | $7.12B |
| Excise taxes on products | $3.14B-12.1% | $3.57B-10.2% | $3.98B-9.7% | $4.41B-10.1% | $4.90B |
| Gross profit | $14.54B+1.2% | $14.37B+0.6% | $14.28B+0.3% | $14.25B+1.8% | $13.99B |
| Marketing, administration and research costs | $2.51B-8.4% | $2.74B+0.0% | $2.74B+17.6% | $2.33B-4.3% | $2.43B |
| Asset impairment and exit costs, net of cash paid | $978.0M+151.4% | $389.0M | $0 | — | — |
| Impairment of goodwill | $1.16B | $0 | $0 | — | — |
| Operating income | $9.90B-11.9% | $11.24B-2.7% | $11.55B-3.1% | $11.92B+3.1% | $11.56B |
| Interest and other debt expense, net | $1.08B+4.1% | $1.04B+4.9% | $989.0M-6.5% | $1.06B-9.0% | $1.16B |
| Net periodic benefit income, excluding service cost | -$59.0M+42.2% | -$102.0M+19.7% | -$127.0M+31.0% | -$184.0M+8.9% | -$202.0M |
| (Income) losses from investments in equity securities | -$510.0M+21.8% | -$652.0M-168.3% | -$243.0M-106.6% | $3.66B-38.9% | $5.98B |
| Gain on the sale of IQOS System commercialization rights | $0+100.0% | -$2.70B | $0 | $0 | — |
| Earnings before income taxes | $9.39B-31.3% | $13.66B+25.0% | $10.93B+47.9% | $7.39B+93.2% | $3.82B |
| Provision for income taxes | $2.44B+2.0% | $2.39B-14.4% | $2.80B+72.2% | $1.63B+20.5% | $1.35B |
| Net earnings | $6.95B-38.3% | $11.26B+38.5% | $8.13B+41.0% | $5.76B+132.9% | $2.48B |
| Basic earnings per share attributable to Altria (in usd per share) | $4.1M-37.0% | $6.5M+43.1% | $4.6M+43.3% | $3.2M+138.1% | $1.3M |
| Diluted earnings per share attributable to Altria (in usd per share) | $4.1M-37.0% | $6.5M+43.1% | $4.6M+43.3% | $3.2M+138.1% | $1.3M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.